the italian cardiovascular epidemiological
TRANSCRIPT
-
8/13/2019 The Italian Cardiovascular Epidemiological.
1/45
Assfrvetaria Fpilfmiacakida DerliavesdacerfItecie`a
\jf Itecie` Derliavesducer FpilfmiacakidecAosfrvetary
(Itec Jfert H ?22 6 (Tuppc 4)8
-
8/13/2019 The Italian Cardiovascular Epidemiological.
2/45
Itec Jfert H Wac 6 Tuppc 4 ?22 fvfry Df`tfr wes nfpt u`lfr quecity da`tracluri`k tjf gifcl warn.
Mftalacakie
I`leki`f sui gettari li risdjia. Mftalacakif ste`ler-lizzetf sa`a stetf elattetf `fcce reddacte f misurezia`flfi gettari li risdjia.
Ce prfssia`f ertfriase stete misurete, prime lfcprfcifva, le u` i`gfrmifrf pragfssia`ecf da` ce pfrsa`ei` pasizia`f sflute, ec oreddia lfstra lapa ecmf`a < mi`uti li ripasa. stete ilf`tigidete ce prfssia`f ertf-riase sistacide f liestacide, damf i`izia lfcce prime f qui`te gesf lfi ta`i li Naratnagg, use`la ca sgikmame- `amftra e mfrduria da` eppraprieta oreddiecf. Ta`astetf ladumf`tetf luf cftturf da`sfdutivf f `fcce`ecisi stete da`silfrete ce mflie lfccf luf misurezia`i. 4Cfpfrsa`f fsemi`etf sa`a stetf sullivisf i` oarlfrci`f fipfrtfsf i` oesf ei vecari li prfssia`f ertfriase risda`-treti f ec trettemf`ta germedacakida. I oarlfrci`f i`dcu-lfve`a qufccf pfrsa`f djf, damf mflie li luf misure-zia`i suddfssivf, prfsf`teve`a vecari damprfsi gre 5 kci ipfrtfsi damprf`-lfve`a dacara djf evfve`a ce prfssia`f ertfriase sista-cide 572 mmJk a ce liestacide 96 mmJk appurffre`a satta rfkacerf trettemf`ta germedacakida. celipasit el-lami`ecf u`e lfccf derettfristidjf djf passa`a da`gi-kurerf ce si`lramf mfteoacide. We qui ridarleta djf e`-djf u` repparta vite/gie`dji 0 2.96 `fkci uami`i f0 2.:6 `fccf la``f da`silfreta i`lidf li elipasit el-lami`ecf4.
Ceoituli`f ec guma li sikerftte, cettivit giside, cu-sa rfkacerf li tfrepif germedacakidjf sa`a steti reddac-ti ettrevfrsa u` qufstia`eria ste`lerlizzeta6. Ceoituli-`f ec guma li sikerftte rikuerleve ic da`suma eoituecfli sikerfttf ec kiar`a ec mamf`ta lfcci`tfrviste, f pfrkci fx gumetari ic da`suma i` pesseta. Ic ;% lfigumetari i`tfrvisteti steta dacpita le i`gerta e reggra`ta
lfc ?% lfi `a` gumetari. I leti qui prfsf`teti si rigfrisda`aecce grfquf`ze li gumetari rfkaceri,dia li dacara djfgume`a u`e a pi sikerfttf ec kiar`a,fl ec `umfra mfliali sikerfttf ec kiar`a pfr gumetarf. e`djf ripartete ce prfvecf`ze lfkci fx gumetari.Ic civfcca lfccettivit giside, ricfveta sfda`la ic quf-stia`eria ki uticizzeta `fccemoita lfc Rrakftta D@_E\T-_G? ak`i sakkftta lavfve i`liderf i` quecf detfkariemfkcia si ilf`tigideve. Rfr qufste e`ecisi cettivit giside stete tresgarmete i` sflf`terie f `a` sflf`terie, quf-
65T
witj tjf Oafjri`kfr _fgcatra` Eddutrf`l Kcudasf lf-vidf. Gar tjis e`ecysis, suohfdts witj ocaal kcudasf 0 lete wfrf damputfl i` oaly mess i`lfx(wfikjt i` nk livilfl oy jfikjt i` m?). I` tjis e`ecysistjf oaly mess i`lfx wes usfl ta lfgi`f avfrwfikjt e`laofsity. Rfrsa`s witj e oaly mess i`lfx oftwff` ?6e`l ?9 nk/m? wfrf da`silfrfl avfrwfikjt, wjicf tjasfwitj e oaly mess i`lfx 42 nk/m? wfrf da`silfrflaofsf.
Jips e`l weist wfrf mfesurfl witj e tepfci`f, tjfsuohfdt i` ste`li`k pasitia`. \jf weist wes mfesurfl etmflium pai`t oftwff` cawfr flkf ag dastec erdj e`luppfr flkf ag icied drfst, wjicf fxjeci`k. Jips wfrfmfesurfl et gra`t e`l uppfr icied spi`fs i`lfpf`lf`tcyag tjf pasitia` ar sjepf ag outtadns. Mfesurfs wfrf rf-partfl i` df`timftfrs witj e lfdimec (2 ar 6). Emfri-de`5 e`l Furapfe`? kuilfci`fs rfpartfl eolami`ecaofsity es e weist 0 52? dm i` mf` e`l 0 :: dm i` wamf`. Eolami`ec aofsity is a`f ag tjf da`litia`s tjetmey cfel ta e mfteoacid sy`lramf. E weist ta jip retia0 2.96 i` mf` e`l 0 2.:6 i` wamf` is da`silfrfl e` i`-lfx ag eolami`ec aofsity4.
Tmani`k jeoit e`l pjysidec edtivity e`l tjf rfkucerusf ag mflidec tjfrepy wfrf i`vfstiketfl tjraukj este`lerlizfl qufstia``eirf. Tmani`k qufstia``eirfi`-dculfl durrf`t, garmfr e`l `fvfr smanfrs.;% ag smanfrs jele stranf damperfl ta ?% ag fx ar `fvfr smanfrs. Tmani`kjeoit wes da`silfrfl ig tjf suohfdt smanfl a`f ar marfdikerfttfs e ley. Dikerfttf da`sumptia` gar durrf`t e`lgarmfr smanfrs wes rfdarlfl. I` tjf _fsucts sfdtia` tjf`umofr ag dikerfttfs smanfl pfr ley i` smanfrs issjaw`.
Rjysidec edtivity wes daccfdtfl tjraukj e qufstia`-`eirf i`dculi`k < cfvfcs ag fxfrdisf (sflf`tery, micl,malfretf, jfevy) sfperetfcy gar warn e`l cfisurf timf.\jf qufstia``eirf jes ecrfely off` usfl i` e` Itecie`rfsferdj spa`sarfl oy tjf @etia`ec _fsferdj Dau`dic
-
8/13/2019 The Italian Cardiovascular Epidemiological.
4/45
Itec Jfert H Wac 6 Tuppc 4 ?22- trikcidfrili fcfveti (562 mk/lc a 5.; mmac/c)>- oessa JLC (3 3 62 mk/lc a 5.4 mmac/c `fccf la``f)>- prfssia`f ertfriase fcfvete (542/:6 mmJk).Ce gemicierit7pfr mecettif derliavesdaceri etfrasdcf-
ratidjf, pfr ipfrtf`sia`f, liscipilfmif f lieoftf stete i`lekete da` lame`lf rikuerle`ti i gemicieri da`se`kui-`fi li prima krela, da`silfre`la idtus f i`gerta lfc mia-derlia li u` perf`tf li prima krela emmeceta a lfdflu-ta i` ft 3 66 e``i `fkci uami`i f 3 76 e``i `fccf la``f.
6?T
i`k tjf micl, malfretf e`l jfevy detfkarifs i` tjf cet-tfr.
Rjermedacakidec trfetmf`ts da`silfrfl tjf usf age`tijypfrtf`sivf, jypacipilfmid e`l e`tilieoftidlruks, tjf espiri` usf gar prfvf`tia`, arec da`tredfp-tivfs, jarma`f rfpcedfmf`t tjfrepy.
Rrfvecf`df ag derliavesducer lisfesfs, mfteoacidsy`lramf, e`l gemicy jistary. \jf prfsf`df ag e`ki-`e pfdtaris e`l dceulidetia i`tfrmittf`s wes essfssflwitj spfdigid qufstia``eirfs lfvfcapfl oy tjf Ca`la` Tdjaac ag Jykif`f e`l \rapidec Mflidi`f (CTJ\M)6 aroy e jistary ag e dara`ery ertfry oypess kregt ar dara-`ery e`kiapcesty.
\jf prfvecf`df ag acl myaderliec i`gerdtia`s wesfvecuetfl witj tjf CTJ\M qufstia``eirf, i`dculi`ksymptams, jaspitec rfdarls e`l prfsf`df ag spfdigidFDK itfms eddarli`k ta tjf Mi``fsate Dalf6, i` per-tiducer, prfsf`df ag U e`l UT wevfs (itfm 5), `fketivf \ wevf (itfm 6) e`l lysrjytjmies (itfms 7, ; e`l :.4)7.
\jf prfvecf`df ag etriec gioriccetia` wes essfssfl ed-darli`k ta tjf Mi``fsate Dalf (itfm :.4).
\jf prfvecf`df ag stranfs wes fvecuetfl eddarli`kta tjf CTJ\M qufstia``eirf e`l e rfvifw ag jaspitecrfdarls.
Cfgt vf`triducer jypfrtrapjy wes essfssfl eddarl-i`k ta tjf Mi``fsate Dalf (itfm 4.5).
Jfert retf wes decducetfl es tjf evfrekf ag jfert ofets pfr mi`utf oftwff` cfels I e`l W7.
\jf mfteoacid sy`lramf, ecsa n`aw` es i`suci`-rf-siste`df sy`lramf, is djeredtfrizfl oy e` ekkrfketia`ag jypfri`suci` essadietfl witj e` ectfrfl rfkucetia` agkcydfmie, jikj trikcydfrilfs, caw JLC, jikj ocaalprfssurf, e`l eolami`ec aofsity. I` dci`idec predtidf,tjf mfteoacid sy`lramf jes off` rfdf`tcy lfgi`fl oytjf Emfride`? e`l Furapfe`; kuilfci`fs es tjf prfs-f`df, i` tjf semf suohfdt, ag tjrff ar marf ag tjf gac-cawi`k dampa`f`ts8
- df`trec aofsity (weist 0 52? dm i` mf` e`l 0 :: dmi` wamf`)>- ectfrfl kcydfmie rfkucetia` (egtfr gesti`k 552 mk/lcar 7.5 mmac/c)>- jikj trikcydfrilfs (562 mk/lc ar 5.; mmac/c)>- caw JLC (3 3 62mk/lc ar 5.4 mmac/c i` wamf`)>- jikj ocaal prfssurf (542/:6 mmJk).
Gemicy jistary gar etjfrasdcfratid derliavesducerlisfesfs, jypfrtf`sia`, jypfrcipilfmie, e`l lieoftfswes essfssfl witj qufstia`s rfkerli`k girst-lfkrffocaal rfcetivfs, da`silfri`k a`cy mf` 3 66 yfers e`lwamf` 3 76 yfers wja lifl gram ar jel e stranf ar my-aderliec i`gerdtia`.
-
8/13/2019 The Italian Cardiovascular Epidemiological.
5/45
Assfrvetaria Fpilfmiacakida Derliavesdacerf Itecie`a
Rrfsf`tezia`f lfi risucteti
I leti reddacti vf`ka`a prfsf`teti damf mflif f lf- viezia`i ste`lerl pfr cf verieoici da`ti`uf f damf grf- quf`zf pfrdf`tueci pfr qufccf detfkaridjf> sa`a ste`-lerlizzeti pfr ft, da`silfre`la damf rigfrimf`ta cepapacezia`f itecie`e rfsilf`tf ec 599 @arl-Fst, i`dcusive lfi leti reddacti `fi df`tri lfc \rf`ti`aEcta Elikf, Wf`fta, Griuci-Wf`fzie Kiucie, Fmicie _a-mek`e> Df`tra, i`dcusive lfi leti reddacti `fi df`tri lfc-ce \asde`e, Vmorie, Merdjf, Cezia> Tul f Isacf, i`dcu-sive lfi leti reddacti `fi df`tri lfccEoruzza, Macisf,Dempe`ie, Rukcie, Oesicidete, Deceorie, Tidicie, Terlf-k`e.
Wf`ka`a prfsf`teti i leti rfcetivi eccf derettfristidjflfmakregidjf lfc dempia`f li papacezia`f fsemi`eta,ec titaca li stulia f ecca steta divicf, i pri`dipeci gettari lirisdjia derliavesdacerf, ce prfvecf`ze lfccf pri`dipecida`lizia`i e risdjia, ce prfvecf`ze lfccf mecettif der-liavesdaceri f lfcce gemicierit pfr mecettif derliave-sdaceri f pfr ipfrtf`sia`f, liscipilfmie f lieoftf.
V`e lfsdrizia`f e pertf pfr i gettari li risdjia f ceprfvecf`ze lfccf mecettif stete gette pfr cf pfrsa`f lift 76-;< e``i f pfr cf la``f i` mf`apeuse. I leti rf-cetivi eccf la``f i` mf`apeuse sa`a ste`lerlizzeti pfrft> cft mflie lfcce la``e i` mf`apeuse risuctete li 7? e``i> cft mflie ecce mf`apeuse risuctete li 62e``i.
_fsucts
Lete lispceyfl erf sjaw` es mfe` vecufs e`l ste`-lerl lfvietia`s gar da`ti`uaus verieocfs e`l es pfr-df`t gar detfkaridec verieocfs> ekf-ste`lerlizfl ed-darli`k ta tjf Itecie` papucetia` i` 599@artjfest, i`dculi`k lete gram\rf`ti`a Ecta Elikf, Wf`fta, Griuci-Wf`fzie Kiucie,Fmicie _amek`e> Df`tfr, i`dculi`k lete gram \usde`y,Vmorie, Merdjf, Cetium> Tautj e`l Isce`ls, i`dculi`klete gram Eoruzza, Macisf, Dempe`ie, Epucie, Oesici-dete, Deceorie, Tidicy, Terli`ie.
Lfmakrepjid djeredtfristids, fludetia`ec cfvfc,meritec stetus, mehar derliavesducer risn gedtars,prfvecf`df ag jikj-risn da`litia`s, prfvecf`df ag der-liavesducer lisfesfs, gemicy jistary gar derliavesducerlisfesf, jypfrtf`sia`, jypfrdjacfstfracfmie e`l lie-oftfs erf prfsf`tfl.
I` ellitia`, lete a` mf`apeusec wamf` e`l aclfrpfrsa`s 76-;< yfers erf rfpartfl sfperetfcy. Lete rf-cetfl ta mf`apeusec wamf` erf ekf-ste`lerlizfl> tjfmfe` ekf ag mf`apeusec wamf` wes 7? yfers> tjfmfe` ekf et mf`apeusf wes 62 yfers.
Dammf`ta
I` qufste II flizia`f lfccEtce`tf sa`a prfsf`teti,pfr ci`tfre papacezia`f fsemi`ete, leti i`tfkretivi equfcci lfsdritti `fcce I flizia`f> vf`ka`a i`actrf prfsf`-teti pfr ce prime vacte i leti rigfriti e luf kruppi li pa-pacezia`f pertidacermf`tf kreveti lec derida lfccf me-cettif derliavesdaceri f lfi cara gettari li risdjia, kci e`-
zie`i, le `ai lfgi`iti lei 76 ei ;< e``i, f cf la``f i` mf- `apeuse.I` kf`frecf, cfcfvete prfvecf`ze li aofsit, essadie-
te el u`e da`tfmpare`fe fcfvete prfvecf`ze li i`etti-vit giside da`gfrme`a ca soice`diemf`ta tre cf decarifi`tralattf da` cecimf`tezia`f f ce limi`uzia`f lfccfdecarif lispfrsf ettrevfrsa u`ettivit giside rfkacerf,da`sfkuf`ti e demoiemf`ti lfccf eoituli`i li vite evvf-`uti `fkci uctimi lfdf``i. I vecari risda`treti i`lide`adjf e`dare macta si pu gerf mikciare`la cezia`f sukci stici li vite, i` pertidacerf pramuavf`la ezia`i succeu-mf`ta lfccettivit giside, f su u`e se`e ecimf`tezia`f,derettfrizzete leccempie verift li dioi li ariki`f e`i-mecf f vfkftecf, da` cimiteta da`suma li secf, oessada`suma li kressi, spfdiecmf`tf li ariki`f e`imecf,
64T
Dammf`ts
\jf ?`l flitia` ag tjis Etces dampcftfs tjf girst a`f witj `fw lete a` tjf risn gedtar listrioutia` e`l tjfprfvecf`df ag jikj-risn da`litia`s i` tjf papucetia`sempcfl. Lete a` tjf aclfr papucetia` ekfl 76-;
-
8/13/2019 The Italian Cardiovascular Epidemiological.
6/45
Itec Jfert H Wac 6 Tuppc 4 ?22 :8 ?26-;5.
?. Fxpfrt Re`fc a` Lftfdtia`, Fvecuetia`, e`l \rfetmf`t agJikj Ocaal Djacfstfrac i` Elucts. Fxfdutivf Tummeryag tjf \jirl _fpart ag tjf @etia`ec Djacfstfrac Flude-tia` Rrakrem (@DFR) Fxpfrt Re`fc a` Lftfdtia`, Fvecu-etia`, e`l \rfetmf`t ag Jikj Ocaal Djacfstfrac i`Elucts (Eluct \rfetmf`t Re`fc III). HEME ?225> ?:68?
-
8/13/2019 The Italian Cardiovascular Epidemiological.
7/45
@umfrasit lfi pertfdipe`ti pfr sfssa f dcessf li ftVAMI@I
Itecie 46
-
8/13/2019 The Italian Cardiovascular Epidemiological.
8/45
I\ECIEG_FUVF@XEDE_LIEDE
Grfq.Oett./mi`
R_FTTIA@F E_\F_IATE
RETmmJk
RELmmJk 44% 45%
59%5
-
8/13/2019 The Italian Cardiovascular Epidemiological.
9/45
Meritec stetus oy kfakrepjid erfes i` mf` e`l wamf`8 si`kcf, merrifl, livardfl, wilaw.
Fludetia` oy kfakrepjid erfes i` mf` e`l wamf`8 primery, sfda`lery, jikj sdjaac, u`ivfrsity.
6;T
-
8/13/2019 The Italian Cardiovascular Epidemiological.
10/45
R_FTTIA@F E_\F_IATE@A_L-AWFT\
RETmmJk
@A_L-FT\
REL??%
57%:; + 55mmJk
4;%?9%
RETmmJk
RELmmJk
44%
?2%56%
?9% 549 + 5:544 + 5:
546 + 5;
545 + 5;
:; + 9
:4 + 9
:? + 52Oarlfr Ipfrtfsi
Oarlfr IpfrtfsiLA@@F
VAMI@I
DF@\_ATVL f ITACF
RETmmJk
RELmmJk 45% ?9% RET
mmJkREL
mmJk546 + 5:
545 + 5:
:< + 52 5:% 54%
:2 + 52Oarlfr Ipfrtfsi
44% 4
-
8/13/2019 The Italian Cardiovascular Epidemiological.
11/45
\rikcidfrilfmie f CLC@A_L-AWFT\
mk/lc
@A_L-FT\
\rikcidfrili
\rikcidfrilimk/lc
CLCmk/lc
CLCmk/lc
54? + ;9
527 + 65
5?6 + 4:
5?2 + 4;5
-
8/13/2019 The Italian Cardiovascular Epidemiological.
12/45
G_FUVF@XE DE_LIEDE
@A_L-AWFT\
Grfquf`zeOett./mi`
@A_L-FT\
Grfquf`zeOett./mi`
;5 + 55;< + 52
79 + 9
;5 + :LA@@F
VAMI@IDF@\_A
TVL f ITACF
Grfquf`zeOett./mi` Grfquf`ze
Oett./mi`;2 + 52
;4 + 52;5 + 52
;< + 52
Mfe` cfvfcs ag jfert retf i` Itecie` medraerfes. Mf` e`l wamf`.
Misurf e`trapamftridjf
F AOFTI\E@A_L-AWFT\
IMDNk/m
@A_L-FT\
IMDNk/m
Wite/Gie`dji
dm
6?%
46%59% 5:%Wite/
Gie`djidm
-
8/13/2019 The Italian Cardiovascular Epidemiological.
13/45
I@E\\IWI\E GITIDE
@A_L-AWFT\
46%??%
4:%?9%
@A_L-FT\
4
-
8/13/2019 The Italian Cardiovascular Epidemiological.
14/45
I\ECIE
5,6%
2,
-
8/13/2019 The Italian Cardiovascular Epidemiological.
15/45
I\ECIE
5,5% 2,:%
ID\VT
LA@@F
VAMI@I
2,:%
2,:%2,;%
\IE
2,7%
Gioriccezia`f Etriecf
Itecy. Rrfvecf`df ag derliavesducer lisfesfs8 stranf, \IE, etriec gioriccetia`. Mf` e`l wamf`.
74T
-
8/13/2019 The Italian Cardiovascular Epidemiological.
16/45
@A_L-AWFT\
5,7%
2,5%
I@GE_\A
-
8/13/2019 The Italian Cardiovascular Epidemiological.
17/45
-
8/13/2019 The Italian Cardiovascular Epidemiological.
18/45
Lieoftf f Ti`lramf Mfteoacide@A_L-FT\
@A_L-AWFT\
?2%
59%;%
-
8/13/2019 The Italian Cardiovascular Epidemiological.
19/45
Gemicierit pfrcf MDW
@A_L-AWFT\?4%
4
-
8/13/2019 The Italian Cardiovascular Epidemiological.
20/45
-
8/13/2019 The Italian Cardiovascular Epidemiological.
21/45
DF@\_A
5,5%2,6%
ID\VT
LA@@F
VAMI@I2,9%
2,6% 2,
-
8/13/2019 The Italian Cardiovascular Epidemiological.
22/45
I\ECIE
76;
-
8/13/2019 The Italian Cardiovascular Epidemiological.
23/45
-
8/13/2019 The Italian Cardiovascular Epidemiological.
24/45
R_FTTIA@F E_\F_IATE@A_L-AWFT\
-
8/13/2019 The Italian Cardiovascular Epidemiological.
25/45
\rikcidfrilfmie f CLC@A_L-AWFT\
mk/lc
@A_L-FT\
\rikcidfrili
\rikcidfrilimk/lc
CLCmk/lc
CLCmk/lc
5?6 + 75
5?5 + 67
5?4 + 46
5?7 + 4:5?9 + 725?5 + 65
542 + 4
-
8/13/2019 The Italian Cardiovascular Epidemiological.
26/45
G_FUVF@XE DE_LIEDE
@A_L-AWFT\
Grfquf`zeOett./mi`
@A_L-FT\
Grfquf`zeOett./mi`
;? + 52;< + 55
;2 + 52
;2 + 9LA@@F
76;
-
8/13/2019 The Italian Cardiovascular Epidemiological.
27/45
I@E\\IWI\E GITIDE
@A_L-AWFT\
49% 4?%?6%
@A_L-FT\
49% 4;%
?2%7%
Cevara \fmpa ciofra52%
Cevara \fmpa ciofra LA@@F
76;
-
8/13/2019 The Italian Cardiovascular Epidemiological.
28/45
76;
-
8/13/2019 The Italian Cardiovascular Epidemiological.
29/45
76;
-
8/13/2019 The Italian Cardiovascular Epidemiological.
30/45
76;
-
8/13/2019 The Italian Cardiovascular Epidemiological.
31/45
76 - ;
-
8/13/2019 The Italian Cardiovascular Epidemiological.
32/45
Lieoftf f Ti`lramf Mfteoacide@A_L-FT\
@A_L-AWFT\
?;%
?4%5
-
8/13/2019 The Italian Cardiovascular Epidemiological.
33/45
Gemicierit pfrcf MDW
@A_L-AWFT\
5:%
?;%44%
@A_L-FT\
42%
LA@@F
76;
-
8/13/2019 The Italian Cardiovascular Epidemiological.
34/45
@A_L-AWFT\76;
-
8/13/2019 The Italian Cardiovascular Epidemiological.
35/45
76;
-
8/13/2019 The Italian Cardiovascular Epidemiological.
36/45
I\ECIEG_FUVF@XEDE_LIEDE
Grfquf`zeOett./mi`
R_FTTIA@F E_\F_IATE
-
8/13/2019 The Italian Cardiovascular Epidemiological.
37/45
R_FTTIA@F E_\F_IATE@A_L-AWFT\
RET
-
8/13/2019 The Italian Cardiovascular Epidemiological.
38/45
\rikcidfrilfmie f CLC@A_L-AWFT\
\rikcidfrilimk/lc
@A_L-FT\
\rikcidfrilimk/lc
CLCmk/lc
CLCmk/lc 559 + 67 542 + 4:
55: + 66 5
-
8/13/2019 The Italian Cardiovascular Epidemiological.
39/45
G_FUVF@XE DE_LIEDE
@A_L-AWFT\
Grfquf`zeOett./mi`
@A_L-FT\
Grfquf`zeOett./mi`
;4 + 52;2 + 9
LA@@FI@
MF@AREVTE
DF@\_ATVL f ITACF
Grfquf`zeOett./mi` Grfquf`ze
Oett./mi`;? + 52
;4 + 52
Mfe` cfvfcs ag jfert retf i` Itecie` medraerfes. Mf`apeusec wamf`.
Misurf e`trapamftridjf
F AOFTI\E@A_L-AWFT\
IMDNk/m
@A_L-FT\
IMDNk/m
Wite/Gie`dji
dm
-
8/13/2019 The Italian Cardiovascular Epidemiological.
40/45
I@E\\IWI\E GITIDE
@A_L-AWFT\
-
8/13/2019 The Italian Cardiovascular Epidemiological.
41/45
I\ECIE
6,:%
2,:%
I@GE_\A E@KI@E
5,?%
4,2%
5,6%
LA@@FI@
MF@AREVTE
\IE
5,4%
IpfrtragieWf`tridacerf
Ti`istre
DceulidetiaI`tfrmittf`s
5,?%
ID\VT
Gioriccezia`fEtriecf
Itecy. Rrfvecf`df ag derliavesducer lisfesfs8 myaderliec i`gerdtia`, e`ki`e pfdtaris, cfgt vf`triducer jypfrtrapjy, dceulidetia i`tfr-mittf`s, stranf, \IE, etriec gioriccetia`. Mf`apeusec wamf`.
:9T
-
8/13/2019 The Italian Cardiovascular Epidemiological.
42/45
@A_L-AWFT\
7,5% 5,
-
8/13/2019 The Italian Cardiovascular Epidemiological.
43/45
DF@\_A
7,?%2,:%
ID\VT5,5%
I@GE_\A E@KI@E
?,
-
8/13/2019 The Italian Cardiovascular Epidemiological.
44/45
Lieoftf f Ti`lramf Mfteoacide@A_L-FT\
@A_L-AWFT\?7%
?4%
7%
9%
LIEOF\F
LIEOF\F Ti`lramf Mfteoacide
Ti`lramf Mfteoacide
LA@@FI@
MF@AREVTE
TVL f ITACFDF@\_A
46%
-
8/13/2019 The Italian Cardiovascular Epidemiological.
45/45
Gemicierit pfrcf MDW
@A_L-AWFT\46%
@A_L-FT\
?9%
LA@@FI@
MF@AREVTE
DF@\_ATVL f ITACF
?6%?9%
Gemicy jistary ag derliavesducer lisfesfs i` Itecie` medraerfes. Mf`apeusec wamf`.